|
Status |
Public on Feb 11, 2022 |
Title |
Increased expression of p53 with APR-246 (eprenetapopt) reprograms tumor-associated macrophages to promote the efficacy of immune checkpoint blockade |
Organism |
Mus musculus |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Expression of genes in sorted CD4, CD8 and non-T CD45 cells isolated from TME of B16 tumors in wildtype B6, APR-246 treated wildtype B6 and Super p53 mice.
|
|
|
Overall design |
mice bearing B16 tumors were implanted in super p53 or WT mice. WT mice were treated with vehicle or APR-246 starting day 7 for 6 days and single cell suspensions of the tumors were obtained and antibody stained for CD45, CD8. CD4 and live/dead. CD45+ CD8+, CD45+CD8+ and CD45+CD4-CD8- sorted and RNA was extracted with the PAXgene RNA kit and purified in accordance with the manufacturer’s protocols. RNA was assessed with the Agilent BioAnalyzer for quantity and quality.
|
|
|
Contributor(s) |
Ghosh A, Mergoub T, Ho Y |
Citation(s) |
36106631 |
|
Submission date |
Feb 11, 2021 |
Last update date |
Oct 04, 2022 |
Contact name |
Yu-Jui Ho |
E-mail(s) |
hoy@mskcc.org
|
Organization name |
Memorial Sloan Kettering Cancer Center
|
Department |
Cancer Biology & Genetics Program
|
Street address |
417 E 68th St
|
City |
New York |
State/province |
New York |
ZIP/Postal code |
10065 |
Country |
USA |
|
|
Platforms (1) |
GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
Samples (37)
|
|
Relations |
BioProject |
PRJNA701459 |
SRA |
SRP305909 |